Sirio Pharma Asset Resilience Ratio
Sirio Pharma asset resilience ratio. Sirio Pharma (300791) has an Asset Resilience Ratio of 0.01% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300791 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sirio Pharma (2020–2024)
Asset resilience ratio of Sirio Pharma from 2020 to 2024. This chart shows how Sirio Pharma's Asset Resilience Ratio has changed over time. Read Sirio Pharma (300791) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sirio Pharma's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Sirio Pharma assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥405.30K | 0.01% |
| Total Liquid Assets | CN¥405.30K | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Sirio Pharma maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sirio Pharma Industry Peers by Asset Resilience Ratio
Compare Sirio Pharma's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Nestle S.A.
SW:NESN |
Packaged Foods | 2.01% |
|
The Magnum Ice Cream Company N.V.
AS:MICC |
Packaged Foods | 0.11% |
|
COFCO Tunhe Sugar Co Ltd
SHG:600737 |
Packaged Foods | 0.08% |
|
The a2 Milk Company Ltd
AU:A2M |
Packaged Foods | 5.10% |
|
Lotus Health Group Co
SHG:600186 |
Packaged Foods | 4.65% |
|
Grupo Herdez S.A.B. de C.V
MX:HERDEZ |
Packaged Foods | 0.22% |
|
Shandong Oriental Ocean Sci-Tech Co Ltd
SHE:002086 |
Packaged Foods | 0.00% |
|
Namchow Food Group (Shanghai) Co. Ltd.
SHG:605339 |
Packaged Foods | 1.48% |
Sirio Pharma Asset Resilience Ratio by Year (2020–2024)
Sirio Pharma asset resilience ratio by year from 2020 to 2024. The table below shows the annual Asset Resilience Ratio data for Sirio Pharma.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.10% | CN¥115.20 Million ≈ $16.86 Million |
CN¥5.49 Billion ≈ $802.78 Million |
-1.76pp |
| 2023-12-31 | 3.86% | CN¥200.66 Million ≈ $29.36 Million |
CN¥5.20 Billion ≈ $760.30 Million |
+1.97pp |
| 2022-12-31 | 1.89% | CN¥79.13 Million ≈ $11.58 Million |
CN¥4.19 Billion ≈ $612.52 Million |
-12.00pp |
| 2021-12-31 | 13.89% | CN¥530.77 Million ≈ $77.67 Million |
CN¥3.82 Billion ≈ $559.00 Million |
-3.98pp |
| 2020-12-31 | 17.87% | CN¥473.49 Million ≈ $69.29 Million |
CN¥2.65 Billion ≈ $387.73 Million |
-- |
About Sirio Pharma
Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. … Read more